Titre : Flavonols

Flavonols : Questions médicales fréquentes

Termes MeSH sélectionnés :

Prothrombin Time

Questions fréquentes et termes MeSH associés

Diagnostic 2

#1

Comment détecte-t-on les flavonols dans les aliments ?

Les flavonols peuvent être détectés par chromatographie et spectrométrie de masse.
Flavonols Chromatographie Spectrométrie de masse
#2

Quels tests mesurent les niveaux de flavonols dans le sang ?

Des tests sanguins spécifiques peuvent quantifier les flavonols et leurs métabolites.
Flavonols Analyse sanguine Métabolites

Symptômes 2

#1

Les flavonols provoquent-ils des symptômes ?

En général, les flavonols ne provoquent pas de symptômes, mais des allergies peuvent survenir.
Flavonols Allergies alimentaires Réactions indésirables
#2

Quels effets des flavonols sur la santé ?

Les flavonols peuvent réduire l'inflammation et améliorer la santé cardiovasculaire.
Flavonols Santé cardiovasculaire Inflammation

Prévention 2

#1

Comment les flavonols aident-ils à prévenir les maladies ?

Ils agissent comme antioxydants, réduisant le stress oxydatif et le risque de maladies.
Flavonols Antioxydants Prévention des maladies
#2

Quels aliments sont riches en flavonols ?

Les oignons, le thé, les baies et le chocolat noir sont de bonnes sources de flavonols.
Flavonols Alimentation Sources alimentaires

Traitements 2

#1

Les flavonols sont-ils utilisés en médecine ?

Oui, les flavonols sont étudiés pour leurs effets bénéfiques sur diverses maladies.
Flavonols Médecine préventive Maladies chroniques
#2

Comment les flavonols aident-ils dans le traitement du cancer ?

Ils peuvent inhiber la croissance tumorale et améliorer l'efficacité des traitements.
Flavonols Cancer Thérapies anticancéreuses

Complications 2

#1

Y a-t-il des complications liées aux flavonols ?

Des interactions médicamenteuses peuvent survenir, mais elles sont rares.
Flavonols Interactions médicamenteuses Complications
#2

Les flavonols peuvent-ils causer des effets secondaires ?

En général, ils sont sûrs, mais des doses élevées peuvent entraîner des troubles digestifs.
Flavonols Effets secondaires Troubles digestifs

Facteurs de risque 2

#1

Qui devrait éviter les flavonols ?

Les personnes allergiques aux flavonoïdes devraient limiter leur consommation de flavonols.
Flavonols Allergies alimentaires Flavonoïdes
#2

Les flavonols sont-ils sûrs pour les femmes enceintes ?

En général, les flavonols sont considérés comme sûrs, mais une consultation médicale est conseillée.
Flavonols Grossesse Sécurité alimentaire
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Flavonols : Questions médicales les plus fréquentes", "headline": "Flavonols : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Flavonols : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-18", "dateModified": "2025-02-12", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Flavonols" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Flavonoïdes", "url": "https://questionsmedicales.fr/mesh/D005419", "about": { "@type": "MedicalCondition", "name": "Flavonoïdes", "code": { "@type": "MedicalCode", "code": "D005419", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.266.450" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Kaempférols", "alternateName": "Kaempferols", "url": "https://questionsmedicales.fr/mesh/D044949", "about": { "@type": "MedicalCondition", "name": "Kaempférols", "code": { "@type": "MedicalCode", "code": "D044949", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.266.450.284.388" } } }, { "@type": "MedicalWebPage", "name": "Quercétine", "alternateName": "Quercetin", "url": "https://questionsmedicales.fr/mesh/D011794", "about": { "@type": "MedicalCondition", "name": "Quercétine", "code": { "@type": "MedicalCode", "code": "D011794", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.266.450.284.777" } } }, { "@type": "MedicalWebPage", "name": "Rutoside", "alternateName": "Rutin", "url": "https://questionsmedicales.fr/mesh/D012431", "about": { "@type": "MedicalCondition", "name": "Rutoside", "code": { "@type": "MedicalCode", "code": "D012431", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.266.450.284.888" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "O-(bêta-Hydroxyéthyl)rutosides", "alternateName": "Hydroxyethylrutoside", "url": "https://questionsmedicales.fr/mesh/D006896", "about": { "@type": "MedicalCondition", "name": "O-(bêta-Hydroxyéthyl)rutosides", "code": { "@type": "MedicalCode", "code": "D006896", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.266.450.284.888.500" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Flavonols", "alternateName": "Flavonols", "code": { "@type": "MedicalCode", "code": "D044948", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Changjie Xu", "url": "https://questionsmedicales.fr/author/Changjie%20Xu", "affiliation": { "@type": "Organization", "name": "Zhejiang Provincial Key Laboratory of Horticultural Plant Integrative Biology, Zhejiang University, Hangzhou 310058, China." } }, { "@type": "Person", "name": "Kunsong Chen", "url": "https://questionsmedicales.fr/author/Kunsong%20Chen", "affiliation": { "@type": "Organization", "name": "Zhejiang Provincial Key Laboratory of Horticultural Plant Integrative Biology, Zhejiang University, Hangzhou 310058, China." } }, { "@type": "Person", "name": "Xian Li", "url": "https://questionsmedicales.fr/author/Xian%20Li", "affiliation": { "@type": "Organization", "name": "Zhejiang Provincial Key Laboratory of Horticultural Plant Integrative Biology, Zhejiang University, Hangzhou 310058, China." } }, { "@type": "Person", "name": "Wei Xue", "url": "https://questionsmedicales.fr/author/Wei%20Xue", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Green Pesticide, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Center for R&D of Fine Chemicals, Guizhou University, Guiyang, 550025, China. wxue@gzu.edu.cn." } }, { "@type": "Person", "name": "Nguyen Xuan Nhiem", "url": "https://questionsmedicales.fr/author/Nguyen%20Xuan%20Nhiem", "affiliation": { "@type": "Organization", "name": "Institute of Marine Biochemistry, Vietnam Academy of Science and Technology, Hanoi, Vietnam." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art.", "datePublished": "2022-09-02", "url": "https://questionsmedicales.fr/article/36055261", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/s-0042-1756196" } }, { "@type": "ScholarlyArticle", "name": "The prothrombin time/international normalized ratio predicts prognosis in cardiogenic shock.", "datePublished": "2023-05-01", "url": "https://questionsmedicales.fr/article/37139569", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MCA.0000000000001241" } }, { "@type": "ScholarlyArticle", "name": "Genetic Polymorphisms Associated with Prothrombin Time and Activated Partial Thromboplastin Time in Chinese Healthy Population.", "datePublished": "2022-10-15", "url": "https://questionsmedicales.fr/article/36292752", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/genes13101867" } }, { "@type": "ScholarlyArticle", "name": "Association of prothrombin time, thrombin time and activated partial thromboplastin time levels with preeclampsia: a systematic review and meta-analysis.", "datePublished": "2024-05-13", "url": "https://questionsmedicales.fr/article/38741046", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12884-024-06543-7" } }, { "@type": "ScholarlyArticle", "name": "Data mining for prothrombin time and international normalized ratio reference intervals in children.", "datePublished": "2022-10-27", "url": "https://questionsmedicales.fr/article/36302050", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0276884" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétérocycliques à cycles fusionnés", "item": "https://questionsmedicales.fr/mesh/D000072471" }, { "@type": "ListItem", "position": 4, "name": "Composés hétérobicycliques", "item": "https://questionsmedicales.fr/mesh/D006574" }, { "@type": "ListItem", "position": 5, "name": "Benzopyranes", "item": "https://questionsmedicales.fr/mesh/D001578" }, { "@type": "ListItem", "position": 6, "name": "4H-1-Benzopyran-4-ones", "item": "https://questionsmedicales.fr/mesh/D002867" }, { "@type": "ListItem", "position": 7, "name": "Flavonoïdes", "item": "https://questionsmedicales.fr/mesh/D005419" }, { "@type": "ListItem", "position": 8, "name": "Flavonols", "item": "https://questionsmedicales.fr/mesh/D044948" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Flavonols - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Flavonols", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Flavonols", "description": "Comment détecte-t-on les flavonols dans les aliments ?\nQuels tests mesurent les niveaux de flavonols dans le sang ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Prothrombin+Time#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Flavonols", "description": "Les flavonols provoquent-ils des symptômes ?\nQuels effets des flavonols sur la santé ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Prothrombin+Time#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Flavonols", "description": "Comment les flavonols aident-ils à prévenir les maladies ?\nQuels aliments sont riches en flavonols ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Prothrombin+Time#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Flavonols", "description": "Les flavonols sont-ils utilisés en médecine ?\nComment les flavonols aident-ils dans le traitement du cancer ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Prothrombin+Time#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Flavonols", "description": "Y a-t-il des complications liées aux flavonols ?\nLes flavonols peuvent-ils causer des effets secondaires ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Prothrombin+Time#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Flavonols", "description": "Qui devrait éviter les flavonols ?\nLes flavonols sont-ils sûrs pour les femmes enceintes ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Prothrombin+Time#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment détecte-t-on les flavonols dans les aliments ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les flavonols peuvent être détectés par chromatographie et spectrométrie de masse." } }, { "@type": "Question", "name": "Quels tests mesurent les niveaux de flavonols dans le sang ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins spécifiques peuvent quantifier les flavonols et leurs métabolites." } }, { "@type": "Question", "name": "Les flavonols provoquent-ils des symptômes ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "En général, les flavonols ne provoquent pas de symptômes, mais des allergies peuvent survenir." } }, { "@type": "Question", "name": "Quels effets des flavonols sur la santé ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les flavonols peuvent réduire l'inflammation et améliorer la santé cardiovasculaire." } }, { "@type": "Question", "name": "Comment les flavonols aident-ils à prévenir les maladies ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Ils agissent comme antioxydants, réduisant le stress oxydatif et le risque de maladies." } }, { "@type": "Question", "name": "Quels aliments sont riches en flavonols ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les oignons, le thé, les baies et le chocolat noir sont de bonnes sources de flavonols." } }, { "@type": "Question", "name": "Les flavonols sont-ils utilisés en médecine ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les flavonols sont étudiés pour leurs effets bénéfiques sur diverses maladies." } }, { "@type": "Question", "name": "Comment les flavonols aident-ils dans le traitement du cancer ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent inhiber la croissance tumorale et améliorer l'efficacité des traitements." } }, { "@type": "Question", "name": "Y a-t-il des complications liées aux flavonols ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des interactions médicamenteuses peuvent survenir, mais elles sont rares." } }, { "@type": "Question", "name": "Les flavonols peuvent-ils causer des effets secondaires ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "En général, ils sont sûrs, mais des doses élevées peuvent entraîner des troubles digestifs." } }, { "@type": "Question", "name": "Qui devrait éviter les flavonols ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes allergiques aux flavonoïdes devraient limiter leur consommation de flavonols." } }, { "@type": "Question", "name": "Les flavonols sont-ils sûrs pour les femmes enceintes ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "En général, les flavonols sont considérés comme sûrs, mais une consultation médicale est conseillée." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 12/02/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Changjie Xu

3 publications dans cette catégorie

Affiliations :
  • Zhejiang Provincial Key Laboratory of Horticultural Plant Integrative Biology, Zhejiang University, Hangzhou 310058, China.
  • Department of Vascular Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China.
Publications dans "Flavonols" :

Kunsong Chen

3 publications dans cette catégorie

Affiliations :
  • Zhejiang Provincial Key Laboratory of Horticultural Plant Integrative Biology, Zhejiang University, Hangzhou 310058, China.
  • Department of Vascular Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China.
Publications dans "Flavonols" :

Xian Li

3 publications dans cette catégorie

Affiliations :
  • Zhejiang Provincial Key Laboratory of Horticultural Plant Integrative Biology, Zhejiang University, Hangzhou 310058, China.
  • Department of Vascular Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China.
Publications dans "Flavonols" :

Wei Xue

3 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Green Pesticide, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Center for R&D of Fine Chemicals, Guizhou University, Guiyang, 550025, China. wxue@gzu.edu.cn.

Nguyen Xuan Nhiem

2 publications dans cette catégorie

Affiliations :
  • Institute of Marine Biochemistry, Vietnam Academy of Science and Technology, Hanoi, Vietnam.
Publications dans "Flavonols" :

Phan Van Kiem

2 publications dans cette catégorie

Affiliations :
  • Institute of Marine Biochemistry, Vietnam Academy of Science and Technology, Hanoi, Vietnam.
Publications dans "Flavonols" :

So Young Lee

2 publications dans cette catégorie

Affiliations :
  • Department of Biomedical and Pharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
Publications dans "Flavonols" :

Yea Jung Choi

2 publications dans cette catégorie

Affiliations :
  • College of Korean Medicine, Gachon University, Seongnam 13120, Republic of Korea.
Publications dans "Flavonols" :

So-Ri Son

2 publications dans cette catégorie

Affiliations :
  • Department of Biomedical and Pharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
Publications dans "Flavonols" :

Sullim Lee

2 publications dans cette catégorie

Affiliations :
  • Department of Life Science, College of Bio-Nano Technology, Gachon University, Seongnam 13120, Republic of Korea.
Publications dans "Flavonols" :

Dae Sik Jang

2 publications dans cette catégorie

Affiliations :
  • Department of Biomedical and Pharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
Publications dans "Flavonols" :

Jesus Simal-Gandara

2 publications dans cette catégorie

Affiliations :
  • Universidade de Vigo, Nutrition and Bromatology Group, Department of Analytical and Food Chemistry, Faculty of Sciences, 32004, Ourense, Spain.
Publications dans "Flavonols" :

Hui Cao

2 publications dans cette catégorie

Affiliations :
  • College of Food Science and Technology, Guangdong Ocean University, Guangdong Provincial Key Laboratory of Aquatic Product Processing and Safety, Zhanjiang, 524088, China.
  • Universidade de Vigo, Nutrition and Bromatology Group, Department of Analytical and Food Chemistry, Faculty of Sciences, 32004, Ourense, Spain.
Publications dans "Flavonols" :

Joanna Popiolek-Kalisz

2 publications dans cette catégorie

Affiliations :
  • Department of Bioanalytics, Medical University of Lublin, 20-090 Lublin, Poland.
  • Department of Cardiology, Cardinal Wyszynski Hospital in Lublin, 20-718 Lublin, Poland.

Xiaolan Jiang

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Tea Plant Biology and Utilization, and International Joint Laboratory on Tea Chemistry and Health Effects of Ministry of Education, Anhui Agricultural University, Hefei, Anhui, China.
Publications dans "Flavonols" :

Yufeng Shi

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Tea Plant Biology and Utilization, and International Joint Laboratory on Tea Chemistry and Health Effects of Ministry of Education, Anhui Agricultural University, Hefei, Anhui, China.
Publications dans "Flavonols" :

Zhouping Fu

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Tea Plant Biology and Utilization, and International Joint Laboratory on Tea Chemistry and Health Effects of Ministry of Education, Anhui Agricultural University, Hefei, Anhui, China.
Publications dans "Flavonols" :

Wei-Wei Li

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Tea Plant Biology and Utilization, and International Joint Laboratory on Tea Chemistry and Health Effects of Ministry of Education, Anhui Agricultural University, Hefei, Anhui, China.
Publications dans "Flavonols" :

Sanyan Lai

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Tea Plant Biology and Utilization, and International Joint Laboratory on Tea Chemistry and Health Effects of Ministry of Education, Anhui Agricultural University, Hefei, Anhui, China.
Publications dans "Flavonols" :

Yajun Liu

2 publications dans cette catégorie

Affiliations :
  • School of Life Science, Anhui Agricultural University, Hefei, Anhui, China.
Publications dans "Flavonols" :

Sources (10000 au total)

The prothrombin time/international normalized ratio predicts prognosis in cardiogenic shock.

The study investigates the prognostic impact of the prothrombin time/international normalized ratio (PT/INR) in patients with cardiogenic shock.... Despite ongoing improvements regarding the treatment of cardiogenic shock patients, intensive care unit (ICU)-related mortality in cardiogenic shock patients remains unacceptably high. Limited data re... All consecutive patients with cardiogenic shock from 2019 to 2021 were included at one institution. Laboratory values were collected from the day of disease onset (day 1) and days 2, 3, 4 and 8. The p... Two hundred twenty-four cardiogenic shock patients were included with a rate of all-cause mortality at 30 days of 52%. The median PT/INR on day 1 was 1.17. The PT/INR on day 1 was able to discriminate... Baseline PT/INR and an increase of the PT/INR during the course of ICU treatment were associated with the risk of 30-day all-cause mortality in cardiogenic shock patients....

Association of prothrombin time, thrombin time and activated partial thromboplastin time levels with preeclampsia: a systematic review and meta-analysis.

Preeclampsia (PE), an obstetric disorder, remains one of the leading causes of maternal and infant mortality worldwide. In individuals with PE, the coagulation-fibrinolytic system is believed to be am... This systematic review and meta-analysis was conducted in accordance with the PRISMA guidelines. Articles relevant to the study, published from July 26, 2013, to July 26, 2023, were systematically sea... A total of 30 articles, involving 5,964 individuals (2,883 with PE and 3,081 as normotensive pregnant mothers), were included in this study. The overall pooled SMD for PT, APTT, and TT between PE and ... The meta-analysis underscores the association between PE and prolonged PT and APTT. This suggests that evaluating coagulation parameters like PT, APTT, and TT in pregnant women could offer easily acce...

Risk stratification and prognostic value of prothrombin time and activated partial thromboplastin time among COVID-19 patients.

COVID-19 is a viral disease caused by a new strain of corona virus. Currently, prognosis and risk stratification of COVID-19 patients is done by the disease's clinical presentation. Therefore, identif... A follow-up study was conducted among conveniently recruited COVID-19 patients attended from March to June 2021. Socio-demographic and clinical data were collected using a structured questionnaire and... Baseline PT at a cut-off value ≥ 16.25 seconds differentiated severe COVID-19 patients from mild and moderate patients (AUC: 0.89, 95% CI: 0.83-0.95). PT also differentiated mild COVID-19 patients fro... Prolonged baseline PT was observed in severe COVID-19 patients. Prolonged baseline PT was also predicted to worsen prognosis. An increase from the baseline PT was associated with worsen prognosis. The...

Association between admission prothrombin time activity and hospital readmission in heart failure: A retrospective study.

Coagulopathy is a common complication of heart failure (HF), but the prognostic significance of coagulation abnormalities for HF is still poorly understood. This investigation sought to elucidate the ... In this retrospective study, we extracted data from a publicly accessible database for hospitalized HF patients in China. The admission laboratory findings were screened by the least absolute shrinkag... A total of 1505 HF patients were included, of whom 58.7% were female and 35.6% were between 70 and 79 y. In LASSO procedure, admission PTA level was included in optimized models for short-term readmis... Low admission PTA level is associated with an increased risk of 90-day and 180-day hospital readmission in patients with HF....

Patient with End-Stage Liver Disease and Prolonged Prothrombin Time Presents for Placement of a New Dental Implant.

Dentists should consult with the patient's hepatologist to obtain the most recent medical records with liver function tests and a coagulation panel. In the absence of severe liver dysfunction and with...